ESMO 2026 news: New data on Moderna-Merck cancer vaccine

Andrew covers the biopharma business, scientific analysis, and public well being throughout the continent. You may attain Andrew confidentially on Sign at drewqjoseph.71.

Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Avenue, and biotechnology. He’s additionally a co-host of the weekly biotech podcast The Readout Loud and creator of the publication Adam’s Biotech Scorecard. You may attain Adam on Sign at stataf.54.

You’re studying our ESMO in 30 Seconds publication. Enroll right here to get updates from the main European most cancers convention in your inbox.

Good day from Madrid, the place this 12 months’s European Society for Medical Oncology convention obtained off to an surprising begin with the leak of the assembly’s most anticipated knowledge. See beneath for a rundown of what’s occurred, and stick with us the following few days as we cowl the response to that examine and a complete lot extra. We’re at [email protected] and [email protected] for any ideas, questions, or opinions on what makes an excellent vermouth. 

The Moderna-Merck melanoma most cancers vaccine knowledge arrived early 

As reporters, nothing juices your adrenaline, or spikes your frustration, greater than a significant embargo violation of essentially the most extremely anticipated knowledge presentation at ESMO. All fastidiously laid plans went proper out the window on the eve of the convention. We have been NOT the responsible social gathering.